Simultaneous determination of busulphan in plasma samples by liquid chromatography-electrospray ionization mass spectrometry utilizing microextraction in packed syringe (MEPS) as on-line sample preparation method

Journal of Liquid Chromatography and Related Technologies

Volumn 30, Issue 20, 2007, Pages 3029-3041

  Abdel Rehim, Mohamed ^a,b   Hassan, Zuzana ^c,d   Skansem, Patrik ^a   Hassan, Moustapha ^c,d  

^a ASTRAZENECA R AND D   (Sweden)

^b KARLSTAD UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Busulfan; LC MS MS; MEPS; Pharmacokinetics; TDM

Indexed keywords

DRUG THERAPY; ELECTROSPRAY IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BUSULFAN; DRUG MONITORING; MICROEXTRACTION IN PACKED SYRINGE (MEPS);

PHARMACOKINETICS;

BUSULFAN;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DERIVATIZATION; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; ONLINE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLID PHASE MICROEXTRACTION; STEM CELL TRANSPLANTATION; SYRINGE; VALIDATION PROCESS;

EID: 35148827438     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070701632337     Document Type: Article

References (29)

1. Vassal, G.; Deroussent, A.; Hartmann, O.; Challine, D.; Benhamou, E.; Valteau-Couanet, D. Dose-dependent neurotoxicity of high-dose busulfan in children: A clinical and pharmacological study. Cancer Res. 1990, 50, 6203-6207.
2. Bearman, S.I. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995, 85, 3005-3020.
3. Hassan, M.; Ljungman, P.; Bolme, P.; Ringden, O.; Syruckova, Z.; Bekassy, A. Busulfan bioavailability. Blood 1994, 84, 2144-2150.
4. Hassan, M.; Oberg, G.; Bekassy, A.N.; Aschan, J.; Ehrsson, H.; Ljungman, P. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology. Cancer Chemother. Pharmacol. 1991, 28, 130-134.
5. Regazzi, M.B.; Locatelli, F.; Buggia, I.; Bonetti, F.; Zecca, M.; Pregnolato, M. Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation. Clin Pharmacol. Ther. 1993, 54, 45-52.
6. 2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992, 79, 2475-2479.
7. Vassal, G.; Fischer, A.; Challine, D.; Boland, I.; Ledheist, F.; Lemerle, S. Busulfan disposition below the age of three: Alteration in children with lysosomal storage disease. Blood 1993, 82, 1030-1034.
8. Hassan, M.; Fasth, A.; Gerritsen, B.; Haraldsson, A.; Syruckova, Z.; van den Berg, H. Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders. Bone Marrow Transplant 1996, 18, 843-850.
9. Buggia, I.; Zecca, M.; Alessandrino, E.P.; Locatelli, F.; Rosti, G.; Bosi, A. Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Anticancer Res. 1996, 16, 2083-2088.
10. Slattery, J.T.; Sanders, J.E.; Buckner, C.D.; Schaffer, R.L.; Lambert, K.W.; Langer, F.P. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics [published erratum appears in Bone Marrow Transplant 1996 Oct, 18(4):829]. Bone Marrow Transplant 1995, 16, 31-42.
11. Bolinger, A.M.; Zangwill, A.B.; Slattery, J.T.; Glidden, D.; DeSantes, K.; Heyn, L. An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease. Bone Marrow Transplant 2000, 25, 925-930.
12. Slattery, J.T.; Clift, R.A.; Buckner, C.D.; Radich, J.; Storer, B.; Bensinger, W.I. Marrow transplantation for chronic myeloid leukemia: The influence of plasma busulfan levels on the outcome of transplantation. Blood 1997, 89, 3055-3060.
13. Grochow, L.B. Busulfan disposition: The role of therapeutic monitoring in bone marrow transplantation induction regimens. Semin. Oncol. 1993, 20 (4 Suppl 4), 18-25.
14. Dix, S.P.; Wingard, J.R.; Mullins, R.E.; Jerkunica, I.; Davidson, T.G.; Gilmore, C.E. Association of busulfan area under the curve with veno-occlusive disease following BMT. Bone Marrow Transplant 1996, 17, 225-230.
15. Masson, E.; Zamboni, W.C. Pharmacokinetic optimisation of cancer chemotherapy effect on outcomes. Clin. Pharmacokinet. 1997, 32, 324-343.
16. McCune, J.S.; Gibbs, J.P.; Slattery, J.T. Plasma concentration monitoring of busulfan: Does it improve clinical outcome? Clin. Pharmacokinet. 2000, 39, 155-165.
17. Chattergoon, D.S.; Saunders, E.F.; Klein, J.; Calderwood, S.; Doyle, J.; Freedman, M.H. An improved limited sampling method for individualised busulphan dosing in bone marrow transplantation in children. Bone Marrow Transplant 1997, 20, 347-354.
18. Hassan, M.; Ehrsson, H. Gas chromatographic determination of busulfan in plasma with electron-capture detection. J. Chromatogr. 1983, 277, 374-380.
19. Vassal, G.; Re, M.; Gouyette. Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard. J. Chromatogr. 1988, 428, 357-361.
20. Quernin, MH.; Poonkuzhali, B.; Montes, C.; Krishnamoorthy, R.; Dennison, D.; Srivastava, A.; Vilmer, E.; Chandy, M.; Jacqz-Aigrain, E. Quantification of busulfan in plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol. J. Chromatogr. B 1998, 709, 47-56.
21. Abdel-Rehim, M.; Hassan, Z.; Blomberg, L.; Hassan, M. On-line derivatization utilizing solid-phase microextraction (SPME) for determination of busulphan in plasma using gas chromatography-mass spectrometry (GC-MS). Therapeutic Drug Monitoring 2003, 25, 400-406.
22. Oechtering, D.; Boos, J.; Hempel, G.J.; Chromatogr, B. Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometry 2006, 838, 129-134.
23. Abdel-Rehim, M. New trends in sample preparation: Online microextraction in packed syringe for liquid and gas chromatography applications. I. Determination of local anaesthetics in human plasma samples using gas chromatography-mass spectrometry. J. Chromatogr. B. 2004, 801, 317-321.
24. Abdel-Rehim, M.; Altun, Z.; Blomberg, L.G. Microextraction in packed syringe (MEPS) for liquid and gas chromatographic applications. Part II-Determination of ropivacaine and its metabolites in human plasma samples using MEPS with liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2004, 39, 1488-1493.
25. Vita, M.; Skansen, P.; Hassan, M.; Abdel-Rehim, M. Development and validation of a liquid chromatography and tandem mass spectrometry method for determination of roscovitine in plasma and urine samples utilizing on-line sample preparation. J. Chromatogr. B. 2005, 817, 303-307.
26. Abdel-Rehim, M.; Altun, Z.; Jagerdeo, E.; Blomberg, L. Drug screening using microextraction in packed syringe (MEPS)/LC-MS utilizing monolithic-based sorbent material. LCT&RT. 2006, 29, 829-839.
27. El-Beqqali, A.; Kussak, A.; Abdel-Rehim, M. Fast and sensitive environmental analysis utilizing micro extraction in packed syringe online with gas chromatography-mass spectrometry: Determination of polycyclic aromatic hydrocarbons in water. J. Chromatogr. A. 2006, 1114, 234-238.
28. Hassan, M.; Oberg, G.; Bjorkholm, M.; Wallin, I.; Lindgren, M. Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics. Cancer Chemother. Pharmacol. 1993, 33, 81-86.
29. Shah, V.P.; Midha, K.K.; Findlay, J.W.A.; Hill, H.M.; Hulse, J.D.; McGilvery, I.J.; McKay, K.; Miller, K.J.; Patnaik, R.N.; Powell, M.L.; Tonelli, A.; Viswanathan, C.T.; Yacobi, A. Analytical methods validation-A revisit with a decade of progress. Pharm. Research 2000, 17, 1551-1557.